N. Dinccag Et Al. , "The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey," 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) , vol.54, Lisbon, Portugal, 2011
Dinccag, N. Et Al. 2011. The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey. 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) , (Lisbon, Portugal).
Dinccag, N., Satman, I., Kalaca, S., Omer, B., Karsidag, K., Yilmaz, T., ... Tutuncu, Y.(2011). The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey . 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Lisbon, Portugal
Dinccag, N. Et Al. "The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey," 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Lisbon, Portugal, 2011
Dinccag, N. Et Al. "The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey." 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) , Lisbon, Portugal, 2011
Dinccag, N. Et Al. (2011) . "The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey." 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) , Lisbon, Portugal.
@conferencepaper{conferencepaper, author={N. Dinccag Et Al. }, title={The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey}, congress name={47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)}, city={Lisbon}, country={Portugal}, year={2011}}